Prisma Health Cancer Institute - Greer — Greer, South Carolina

Prisma Health Cancer Institute - Greer is a clinical research site located in Greer, South Carolina, United States 29650.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Prisma Health Cancer Institute - Greer has participated in 229 clinical trials with 153 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greer

Browse all research sites in South Carolina · View every site in Greer

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health Cancer Institute - Greer?

Prisma Health Cancer Institute - Greer has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health Cancer Institute - Greer conducted?

Prisma Health Cancer Institute - Greer has 229 clinical trials on record, with 153 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Prisma Health Cancer Institute - Greer accredited by Crixeo Clinical Trials?

Prisma Health Cancer Institute - Greer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health Cancer Institute - Greer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.